×

Valeant Will Release Third-Quarter 2017 Financial Results On November 7

LAVAL, Quebec, Oct. 3, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ("Valeant") will release its third-quarter 2017 financial results on Tuesday, Nov. 7, 2017. Valeant will host a conference call and live web cast at 8:00 a.m. EST to discuss the results and provide a business update. All materials will be made available on the investor relations section of the Valeant web site prior to the start of the call.

Conference Call Details

Date:

Tuesday, Nov. 7, 2017

Time:

8:00 a.m. EST

Webcast:

http://ir.valeant.com/events-and-presentations

Participant Event Dial-in:

(844) 428-3520 (North America)


(409) 767-8386 (International)

Participant Passcode:

91700211

Replay Dial-in:

(855) 859-2056 (North America)


(404) 537-3406 (International)

Replay Passcode:

91700211 (replay available until Jan. 7, 2018)

About Valeant
Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. More information about Valeant can be found at www.valeant.com.

Investor Contact:

Media Contact:

Arthur Shannon

Lainie Keller

arthur.shannon@valeant.com

lainie.keller@valeant.com

(514) 856-3855

(908) 927-0617

(877) 281-6642 (toll free)


View original content with multimedia:http://www.prnewswire.com/news-releases/valeant-will-release-third-quarter-2017-financial-results-on-november-7-300528475.html

SOURCE Valeant Pharmaceuticals International, Inc.